Koh J, Suh KJ, Park HY, Kwon HJ, et al. Heterogeneity of breast and nodal response to neoadjuvant pembrolizumab-based chemoimmunotherapy in early triple-negative breast cancer and its clinical significance. Histopathology 2026 Sep 24. doi: 10.1111/his.70285.
PMID: 42781819